Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

BACKGROUND: Prostate cancer screening depends on a careful balance of benefits, in terms of reduced prostate cancer mortality, and harms, in terms of overdiagnosis and overtreatment. We aimed to estimate the effect on overdiagnosis of restricting prostate specific antigen (PSA) testing by age and ba...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Vickers, Andrew J, Sjoberg, Daniel D, Ulmert, David, Vertosick, Emily, Roobol, Monique J, Thompson, Ian, Heijnsdijk, Eveline AM, De Koning, Harry, Atoria-Swartz, Coral, Scardino, Peter T, Lilja, Hans
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922189/
https://ncbi.nlm.nih.gov/pubmed/24512643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-12-26
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires